In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples